🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Several professionals stated the demand for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the platform has taken down problematic content and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for preparing or injecting at home.

After moments of entering one community, a seller posted contact information, where most transactions occur. The seller sent an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.

Product Details and Costs

Inside these groups, messages display dark colored parcels with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how much time a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service stated it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose users to potentially serious health risks”.